Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Jose Diaz-Chavez"'
Autor:
Myrna Candelaria, Dennis Cerrato-Izaguirre, Olga Gutierrez, Jose Diaz-Chavez, Alejandro Aviles, Alfonso Dueñas-Gonzalez, Luis Malpica
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 17, p 9328 (2024)
Diffuse large B-cell lymphoma (DLBCL) is the most common B-cell malignancy worldwide. Molecular classifications have tried to improve cure rates. We prospectively examined and correlated the mutational landscape with the clinical features and outcome
Externí odkaz:
https://doaj.org/article/63730d008ee04c05bcebaeca123a7e26
Autor:
Alejandro Schcolnik-Cabrera, Alma Chavez-Blanco, Guadalupe Dominguez-Gomez, Mandy Juarez, Ariana Vargas-Castillo, Rafael Isaac Ponce-Toledo, Donna Lai, Sheng Hua, Armando R. Tovar, Nimbe Torres, Delia Perez-Montiel, Jose Diaz-Chavez, Alfonso Duenas-Gonzalez
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract The malignant energetic demands are satisfied through glycolysis, glutaminolysis and de novo synthesis of fatty acids, while the host curses with a state of catabolism and systemic inflammation. The concurrent inhibition of both, tumor anabo
Externí odkaz:
https://doaj.org/article/f99339e0268a4075931c6a4545b04390
Autor:
María D. Pérez-Montiel, Dennis Cerrato-Izaguirre, Yesennia Sánchez-Pérez, Jose Diaz-Chavez, Carlo César Cortés-González, Jairo A. Rubio, Miguel A. Jiménez-Ríos, Luis A. Herrera, Anna Scavuzzo, Abelardo Meneses-García, Ricardo Hernández-Martínez, Felipe Vaca-Paniagua, Andrea Ramírez, Alicia Orozco, David Cantú-de-León, Diddier Prada
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 2, p 1092 (2023)
Bladder cancer (BC) is the most common neoplasm of the urinary tract, which originates in the epithelium that covers the inner surface of the bladder. The molecular BC profile has led to the development of different classifications of non-muscle inva
Externí odkaz:
https://doaj.org/article/1a98f05559194bfc857e51e71ca25fae
Autor:
Jorge Hernandez-Valencia, Enrique Garcia-Villa, Aquetzalli Arenas-Hernandez, Jaime Garcia-Mena, Jose Diaz-Chavez, Patricio Gariglio
Publikováno v:
Nutrients, Vol 10, Iss 9, p 1148 (2018)
Resistance to cisplatin (CDDP) is a major cause of cancer treatment failure, including human breast cancer. The tumor suppressor protein p53 is a key factor in the induction of cell cycle arrest, DNA repair, and apoptosis in response to cellular stim
Externí odkaz:
https://doaj.org/article/8f5f1bc814bc4e09964592ebc9071fe0
Autor:
Myrna Candelaria, Erick de la Cruz-Hernandez, Lucia Taja-Chayeb, Enrique Perez-Cardenas, Catalina Trejo-Becerril, Aurora Gonzalez-Fierro, Alma Chavez-Blanco, Ernesto Soto-Reyes, Guadalupe Dominguez, Jaenai E Trujillo, Jose Diaz-Chavez, Alfonso Duenas-Gonzalez
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e29181 (2012)
BACKGROUND: Down regulation of genes coding for nucleoside transporters and drug metabolism responsible for uptake and metabolic activation of the nucleoside gemcitabine is related with acquired tumor resistance against this agent. Hydralazine has be
Externí odkaz:
https://doaj.org/article/10635800c34a467b85da06632948f974
Autor:
Dennis Cerrato-Izaguirre, Jonathan González-Ruíz, José Diaz-Chavez, Andrea Ramírez, Anna Scavuzzo, Miguel A. Jimenez, Carlo Cortés-González, Jairo A. Rubio, María D. Pérez-Montiel, Claudia M. García-Cuellar, Luis A. Herrera, Yesennia Sánchez-Pérez, Felipe Vaca-Paniagua, Salim Barquet-Muñoz, David Cantu-de-Leon, Promita Bose, Diddier Prada
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Background Health disparities have been highlighted among patient with prostate adenocarcinoma (PRAD) due to ethnicity. Mexican men present a more aggressive disease than other patients resulting in less favorable treatment outcome. We aimed
Externí odkaz:
https://doaj.org/article/aa27e0284ff54b798950f20f0227eccc
Autor:
Donna Lai, Alfonso Dueñas González, Alejandro Schcolnik‑Cabrera, Guadalupe Dominguez‑Gomez, Sheng Hua, Armando R. Tovar, Mandy Juarez, Alma Chavez‑Blanco, Jose Diaz‑Chavez
Publikováno v:
Oncol Lett
Cancer upregulates glycolysis, glutaminolysis and lipogenesis, and induces a catabolic state in patients. The concurrent inhibition of both tumor anabolism and host catabolism, and the energetic consequences of such an approach, have not previously b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5340e175ba01f0e27890bc3c35a8807
https://pubmed.ncbi.nlm.nih.gov/32782623
https://pubmed.ncbi.nlm.nih.gov/32782623
Autor:
Marisol Ramírez‑Yautentzi, Alejandro Schcolnik‑Cabrera, Alma Chavez‑Blanco, Alfonso Dueñas González, Rocío Morales‑Bárcenas, Jose Diaz‑Chavez, Lucía Taja‑Chayeb, Guadalupe Dominguez‑Gomez
Publikováno v:
Oncology Letters
Lonidamine, 6-Diazo-5-oxo-L-norleucine (DON) and orlistat are well known inhibitors of glycolysis, glutaminolysis and of de novo fatty acid synthesis, respectively. Although their antitumor effects have been explored in detail, the potential inhibiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb9cbffba868a8c00fd7fa341ca03eb7
https://doi.org/10.3892/ol.2019.11008
https://doi.org/10.3892/ol.2019.11008
Autor:
Miguel González-Woge, Laura Contreras-Espinosa, José Antonio García-Gordillo, Sergio Aguilar-Villanueva, Enrique Bargallo-Rocha, Paula Cabrera-Galeana, Tania Vasquez-Mata, Ximena Cervantes-López, Diana Sofía Vargas-Lías, Rogelio Montiel-Manríquez, Luis Bautista-Hinojosa, Rosa Rebollar-Vega, Clementina Castro-Hernández, Rosa María Álvarez-Gómez, Inti Alberto De La Rosa-Velázquez, José Díaz-Chávez, Francisco Jiménez-Trejo, Cristian Arriaga-Canon, Luis Alonso Herrera
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 15, p 8077 (2024)
lncRNAs are noncoding transcripts with tissue and cancer specificity. Particularly, in breast cancer, lncRNAs exhibit subtype-specific expression; they are particularly upregulated in luminal tumors. However, no gene signature-based laboratory tests
Externí odkaz:
https://doaj.org/article/2e3f6489a6da47de94ad6217720a3e0a
Autor:
Guadalupe Dominguez‑Gomez, Alejandro Schcolnik‑Cabrera, Jose Diaz‑Chavez, Alfonso Dueñas González, Dominique Cortez‑Pedroza, Fredy Beltran‑Anaya, Aurora Gonzalez‑Fierro, Lucía Taja Chayeb, Alberto Cedro‑Tanda, Alfredo Hidalgo‑Miranda, Alma Chavez‑Blanco
Publikováno v:
Oncology reports. 42(3)
Ribavirin exhibits inhibitory effects on the epigenetic enzyme enhancer of zeste homolog 2 (EZH2), which participates in lymphomagenesis. Additionally, preclinical and clinical studies have demonstrated the anti‑lymphoma activity of this drug. To f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71a38f03437b4f607078cb54bb04c509
https://pubmed.ncbi.nlm.nih.gov/31322273
https://pubmed.ncbi.nlm.nih.gov/31322273